Health and Fitness Health and Fitness
Wed, September 8, 2010
[ Wed, Sep 08th 2010 ] - Market Wire
FDA Advisory Committee Recommends Approval of For .. e Fosamil for the Treatment of Community Acquired
[ Wed, Sep 08th 2010 ] - Market Wire
AngioDynamics Reports Preliminary Fiscal 2011 First Quarter Results
[ Wed, Sep 08th 2010 ] - Market Wire
Kindred Healthcare to Participate in the Stifel Nicolaus 2010 Healthcare Conference
[ Wed, Sep 08th 2010 ] - Market Wire
LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
[ Wed, Sep 08th 2010 ] - Market Wire
Resurrectiona" Showcased to NYC at the Attica 2 Year Anniversary Party
Tue, September 7, 2010
[ Tue, Sep 07th 2010 ] - Market Wire
Northstar Healthcare Announces Waiver of Lock-Up Condition To Private Placement
[ Tue, Sep 07th 2010 ] - Market Wire
NUVO RESEARCH PROVIDES CORPORATE UPDATE
[ Tue, Sep 07th 2010 ] - Market Wire
Zacks' Voice of the People Highlights Opportunities with Candence Pharmaceuticals
[ Tue, Sep 07th 2010 ] - Market Wire
Aeterna Zentaris to Present at Upcoming Rodman Re .. nual Global Investment Conference on September 14
[ Tue, Sep 07th 2010 ] - Market Wire
Cubist Pharmaceuticals Announces Promotion of Ste .. Research and Development and Chief Scientific Of
[ Tue, Sep 07th 2010 ] - Market Wire
Array BioPharma to Present at the Rodman & Rensha .. nce and the Stifel Nicolaus Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
Court Denies Sandoz/Momenta's Summary Judgment of Invalidity in Copaxone® Litigation
[ Tue, Sep 07th 2010 ] - Market Wire
RXi Pharmaceuticals to Webcast Presentation at the Rodman & Renshaw Global Investment Conference
[ Tue, Sep 07th 2010 ] - Market Wire
Teleflex Announces FDA 510(k) Market Clearance of .. e Injectable Peripherally Inserted Central Cathet
[ Tue, Sep 07th 2010 ] - Market Wire
Derma Sciences to Present at the Rodman & Renshaw 12th Annual Global Investment Conference
[ Tue, Sep 07th 2010 ] - Market Wire
Baxter to Present at the Morgan Stanley Global Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
La Jolla Pharmaceutical Company Provides Update o .. ch for Clinical Products to In-License or Acquire
[ Tue, Sep 07th 2010 ] - Market Wire
Medtronic Gains CE Mark for Enhanced CoreValve® .. ery Catheter System with AccuTrak Stability Layer
[ Tue, Sep 07th 2010 ] - Market Wire
BioSante Pharmaceuticals, Inc. to Present at the Rodman & Renshaw Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
St. Jude Medical Signs Equity Investment and Option to Purchase Agreement with CardioMEMS
[ Tue, Sep 07th 2010 ] - Market Wire
Orthofix International to Participate in Morgan Stanley Unplugged Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
CytRx Initiates Phase 2 Clinical Trial with Bafetinib in Advanced Prostate Cancer
[ Tue, Sep 07th 2010 ] - Market Wire
Health Net Federal Services Meets Target Enrollme .. Chronic Obstructive Pulmonary Disease Management
[ Tue, Sep 07th 2010 ] - Market Wire
Somaxon Pharmaceuticals Announces Commercial Availability of Silenor
[ Tue, Sep 07th 2010 ] - Market Wire
Fibrocell Science, Inc. Names Biotechnology and G .. Gruenwald, M.D., Ph.D., to Scientific Advisory B
[ Tue, Sep 07th 2010 ] - Market Wire
Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
Response Genetics, Inc. to Present at the Rodman & Renshaw 12th Annual Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
BioDelivery Sciences Adds New Executive to Lead Business and Strategic Development
[ Tue, Sep 07th 2010 ] - Market Wire
Rosetta Genomics to Present at the Rodman & Renshaw 12th Annual Global Investment Conference
[ Tue, Sep 07th 2010 ] - Market Wire
SuperGen to Present at Rodman & Renshaw Annual Healthcare Conference on September 13th

SuperGen to Present at Rodman & Renshaw Annual Healthcare Conference on September 13th


Published on 2010-09-07 03:41:34 - Market Wire
  Print publication without navigation


DUBLIN, Calif.--([ BUSINESS WIRE ])--SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at the Rodman & Renshaw 12th Annual Healthcare Conference on Monday, September 13th in New York.

SuperGen's presentation will begin at 10:00 a.m. ET. A live webcast of the presentation will be available in the Investor Events section of the Company's Web site at [ www.supergen.com ]. The webcast will be archived for 30 days.

About SuperGen

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit [ http://www.supergen.com ].

Contributing Sources